OpenAI Launches GPT-Rosalind for Life Sciences and Codex Plugin
OpenAI has unveiled GPT-Rosalind, a specialized AI model designed to accelerate life sciences research by synthesizing evidence, generating biological hypotheses, and planning experiments. Named after Rosalind Franklin, the model targets fragmented workflows in genomics, protein engineering, and chemistry. Benchmark tests indicate superior performance, with GPT-Rosalind outperforming previous models on tasks like molecular cloning design and ranking above the 95th percentile of human experts in RNA sequence prediction during a partnership with Dyno Therapeutics. Alongside the model, OpenAI released a Life Sciences research plugin for Codex on GitHub. This plugin serves as an orchestration layer, connecting to over 50 public multi-omics databases and automating repetitive tasks such as protein structure lookups. Due to safety concerns regarding biological redesign capabilities, access is restricted through a Trusted Access program limited to qualified enterprise customers in the United States. Applicants must undergo rigorous safety reviews to ensure beneficial use and strong governance. This launch marks OpenAI's strategic shift from general-purpose assistants to domain-specific reasoning partners, aiming to reduce the time and cost associated with drug discovery and biological research.
Wire timeline
OpenAI Launches GPT-Rosalind for Life Sciences and Codex Plugin
OpenAI has unveiled GPT-Rosalind, a specialized AI model designed to accelerate life sciences research by synthesizing evidence, generating biological hypotheses, and planning experiments. Named after Rosalind Franklin, the model targets fragmented workflows in genomics, protein engineering, and chemistry. Benchmark tests indicate superior performance, with GPT-Rosalind outperforming previous models on tasks like molecular cloning design and ranking above the 95th percentile of human experts in RNA sequence prediction during a partnership with Dyno Therapeutics. Alongside the model, OpenAI released a Life Sciences research plugin for Codex on GitHub. This plugin serves as an orchestration layer, connecting to over 50 public multi-omics databases and automating repetitive tasks such as protein structure lookups. Due to safety concerns regarding biological redesign capabilities, access is restricted through a Trusted Access program limited to qualified enterprise customers in the United States. Applicants must undergo rigorous safety reviews to ensure beneficial use and strong governance. This launch marks OpenAI's strategic shift from general-purpose assistants to domain-specific reasoning partners, aiming to reduce the time and cost associated with drug discovery and biological research.
VentureBeat